Cogent Biosciences, Inc. has grown revenue −2.0% a year over three years and −2.0% a year over five. Revenue growth, 3-year annual rate: −2.0% (Biotechnology median +17%). Revenue growth, 5-year rate: −2.0%, growth has slowed since the five-year average. Years of annual history on file: 9, FY2017 to FY2025, as filed.

COGTCogent Biosciences, Inc.

Healthcare

$29.78+138% 1Y

$29.78

$12.9452 weeks$42.84

Is it growing?

Is COGT growing?

Cogent Biosciences, Inc. has grown revenue −2.0% a year over three years and −2.0% a year over five.

−2.0%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: −2.0%
Revenue growth, 5-year rate · −2.0% over three · growth has slowed since the five-year average
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed

Annual income statements as filed with the SEC.

On our screens:Most shorted stocks

Biotechnology

Ranks #86 of 196 by RyuScore

Compare peers

SRRK-0.60%

Scholar Rock Holding Corporation

CGON-1.1%

CG Oncology, Inc.

PTCT-2.8%

PTC Therapeutics, Inc.

BLTE+3.0%

Belite Bio, Inc

DFTX-4.6%

Definium Therapeutics, Inc.

LGND+3.2%

Ligand Pharmaceuticals Incorporated